BLAISE L.
- Country
- France
- Department
- Service d'Hépatologie
Research Overview
- Evaluation of Metformin on Hepatic Venous Pressure Gradient in Cirrhotic Patients with Portal Hypertension Under Carvedilol Therapy: A Randomized, Placebo-Controlled Trial
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE SOLID DISPERSION (SSD) TABLETS FOR THE DELAY OF ENCEPHALOPATHY DECOMPENSATION IN CIRRHOSIS (RED-C)
Data & Insights
Has run more than one trial at 0 of 67 partner sites.
Specializations
Hepatic Complications
This investigator specializes in the treatment and management of hepatic encephalopathy, focusing particularly on innovative therapeutic approaches for patients with cirrhosis. Their research extends to evaluating new pharmaceutical formulations for preventing encephalopathy-related hospitalizations.
- Hepatic Encephalopathy Management
- Cirrhosis Complications
- Preventive Treatment Strategies
Cirrhosis Management
The investigator focuses on treating patients with asymptomatic cirrhosis, particularly those classified as Child-Pugh A5 to B8. Their work involves long-term therapeutic interventions aimed at preventing disease progression and improving patient outcomes.
- Disease Progression Prevention
- Liver Decompensation Management
- Clinical Assessment Protocols
Portal Hypertension
Expertise in treating portal hypertension in cirrhotic patients forms a core part of this investigator's clinical focus. Their work includes evaluation of combination therapies and novel approaches to managing portal pressure in complicated cirrhosis cases.
- Portal Pressure Management
- Cirrhotic Complications
- Therapeutic Response Assessment
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.